New patent expiration for Teva branded drug PROAIR RESPICLICK – DrugPatentWatch
Annual Drug Patent Expiration for PROAIR+RESPICLICK
Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from a single supplier. There are ten patents protecting this drug.
Drug patent litigation for PROAIR RESPICLICK.
This drug has two hundred and sixty-two patent family members in thirty-one countries.
The generic ingredient in PROAIR RESPICLICK is albuterol sulfate. One registered supplier for this compound. Additional details are available on the albuterol sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally issued at the time the new Patent expired for the drug Teva Branded PROAIR RESPICLICK